ATE476972T1 - Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris - Google Patents

Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris

Info

Publication number
ATE476972T1
ATE476972T1 AT07711939T AT07711939T ATE476972T1 AT E476972 T1 ATE476972 T1 AT E476972T1 AT 07711939 T AT07711939 T AT 07711939T AT 07711939 T AT07711939 T AT 07711939T AT E476972 T1 ATE476972 T1 AT E476972T1
Authority
AT
Austria
Prior art keywords
vpa
acne vulgaris
mild
valproic acid
topical treatment
Prior art date
Application number
AT07711939T
Other languages
English (en)
Inventor
Bernd Hentsch
Sylvia E Schwarz
Original Assignee
Topotarget Germany Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topotarget Germany Ag filed Critical Topotarget Germany Ag
Application granted granted Critical
Publication of ATE476972T1 publication Critical patent/ATE476972T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT07711939T 2006-03-31 2007-03-13 Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris ATE476972T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06006847A EP1839656A1 (de) 2006-03-31 2006-03-31 Verwendung von Valproicsäure zur topischen Verhandung von mild bis mässig Akne Vulgaris
PCT/EP2007/002201 WO2007112832A1 (en) 2006-03-31 2007-03-13 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris

Publications (1)

Publication Number Publication Date
ATE476972T1 true ATE476972T1 (de) 2010-08-15

Family

ID=36498743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07711939T ATE476972T1 (de) 2006-03-31 2007-03-13 Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris

Country Status (6)

Country Link
US (1) US20090186809A1 (de)
EP (2) EP1839656A1 (de)
JP (1) JP2009534306A (de)
AT (1) ATE476972T1 (de)
DE (1) DE602007008385D1 (de)
WO (1) WO2007112832A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492438B2 (en) * 2002-04-26 2013-07-23 Asan Laboratories Company (Cayman), Limited Treatment skin disorders
EP1491188A1 (de) * 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topische Verwendung von Valproinsäure zur Behandlung von Hauterkrankungen
EP2522396A1 (de) 2005-02-03 2012-11-14 TopoTarget UK Limited Kombinationstherapien mit HDAC-Hemmern
CN101189003B (zh) 2005-05-13 2012-02-08 托波塔吉特英国有限公司 Hdac抑制剂的药物制剂
EP2361619A1 (de) * 2005-11-10 2011-08-31 TopoTarget UK Limited Histone Deacetylase (hdac) Inhibitoren (pxd-101) zur Behandlung von hämatologischen Krebserkrankungen
CA2700173C (en) * 2007-09-25 2016-10-11 Topotarget Uk Limited Methods of synthesis of certain hydroxamic acid compounds
SI2262493T1 (sl) * 2008-03-07 2015-07-31 Onxeo Dk Branch Of Onxeo S.A. France Postopki zdravljenja z uporabo podaljšane kontinuirane infuzije belinostata
WO2010077642A1 (en) 2008-12-08 2010-07-08 Northwestern University Method of modulating hsf-1
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
CA2788684C (en) * 2010-02-05 2018-05-01 Asan Laboratories Company (Cayman), Limited Treatment skin disorders
KR101733189B1 (ko) * 2010-10-06 2017-05-08 (주)아모레퍼시픽 손톱 또는 발톱 성장 촉진용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1491188A1 (de) * 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topische Verwendung von Valproinsäure zur Behandlung von Hauterkrankungen
ES2308065T3 (es) * 2004-04-30 2008-12-01 Topotarget Germany Ag Formulacion que comprende un inhibidor de histona desacetilasa, que exhibe una liberacion bifasica.
EP1776358B1 (de) * 2004-07-28 2009-05-27 Janssen Pharmaceutica N.V. Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase

Also Published As

Publication number Publication date
EP1839656A1 (de) 2007-10-03
EP2001458A1 (de) 2008-12-17
US20090186809A1 (en) 2009-07-23
EP2001458B1 (de) 2010-08-11
JP2009534306A (ja) 2009-09-24
WO2007112832A1 (en) 2007-10-11
DE602007008385D1 (de) 2010-09-23

Similar Documents

Publication Publication Date Title
ATE476972T1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
EA200970791A1 (ru) N-АДАМАНТИЛБЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ 11-β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ
WO2008101907A3 (en) N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
DE69933208D1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
BRPI0414581A (pt) derivados de benzimidazol: preparação e aplicações farmacêuticas
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
WO2001039759A3 (en) Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
WO2023078333A8 (zh) 一种取代的苯丙酸衍生物及其用途
NZ598489A (en) Combination therapy for treating proliferative diseases
TW200719882A (en) Treatment of connective tissue diseases of the skin
NO20005912L (no) Sulfonylsyre- eller sulfonylamino-N-(heteroaralkyl)- azaheterocyklylamidforbindelser
SE0400184D0 (sv) New therapeutical use
RU2008127882A (ru) Лечение пищевода барретта
WO2010075287A3 (en) Compounds and methods for the treatment of pain and other diseases
BRPI0415628A (pt) suspensões analgésicas para liberação controlada
WO2006065870A8 (en) Topical numbing composition for laser therapy
BR0318201A (pt) regime de dosagem de fármaco antiinflamatório não-esteroidal
BRPI0415630A (pt) suspensões analgésicas para liberação controlada
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
MY148565A (en) Agent for therapy and/or improvement of disseminated intravascular coagulation
ATE516038T1 (de) Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen
MY158799A (en) New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts
BR0307039A (pt) Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties